Regeneron (NASDAQ: REGN) reported Q2 EPS of $14.29, $3.71 better than the analyst estimate of $10.58. Revenue for the quarter came in at $4.29 billion versus the consensus estimate of $3.8 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.